Passive transfer of Mycoplasma bovis-specific antibodies in calves born to vaccinated dams by Calloway, Christopher Douglas
Public Abstract
First Name: Christopher
Middle Name: Douglas
Last Name: Calloway
Degree: MS
Academic Program: Veterinary Medicine and Surgery
Adviser’s First Name: Loren
Adviser’s Last Name: Schultz
Co-Adviser’s First Name:
Co-Adviser’s Last Name:
Graduation Term: Fall
Graduation Year: 2006
Title: Passive transfer of Mycoplasma bovis-specific antibodies in calves born to vaccinated 
dams
Mycoplasma bovis is a bacterial pathogen that has been shown to cause respiratory disease, 
mastitis, polyarthritis, keratoconjunctivitis, and other diseases in cattle worldwide.  High costs 
associated with these diseases are attributed to treatment, culling, deaths, and purchase of 
replacement animals.  Prevention of M. bovis associated diseases include sound management 
practices similar to those used by beef and dairy cattle managers to prevent other causes of 
respiratory disease and mastitis.  Commercially available vaccinations are also available to 
producers and veterinarians to be used as an added preventative measure. Efficacies of these 
vaccines are still being evaluated.
This research, consisting of two studies, evaluated antibody responses in late gestation dairy 
cattle given a commercially available M. bovis vaccination.  Serum, colostrum, and milk 
antibodies were compared between cows receiving the vaccine and those not receiving the 
vaccine.  The second study evaluated serum antibody response in female calves born to cows 
from the first study.  These calves received colostrum from the cows to which they were born. 
Serum antibody responses were measured before ingestion of colostrum, after ingestion of 
colostrum, and 30 days of age.
Serum and colostrum antibody responses against M. bovis in vaccinated cows were significantly 
greater than those of non-vaccinated cows.   However, there was no difference noted in the 
serum antibody responses between female calves born to vaccinated cows and those born to non-
vaccinated cows.  
Future studies in this area of research are planned.  Female calves born to vaccinated cows and 
non-vaccinated cows will be challenged with varying levels of M. bovis to evaluate differences 
in actual disease rates.  
